Richard Norem, MD
Surgery · Pineville, LANPI 1659376895
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $953 of the $1,533 with a category attached, or 62.2%. Medical Device Business Services, Inc. accounts for 65.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,207 and has fallen 90.5% since, to $115 in 2023. That places this record below the midpoint for surgery clinicians in LA, where the typical reported total is $1,529.
Across 20 payments — averaging $76.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Braintree Laboratories, Inc.$174
- Johnson & Johnson$170
- AbbVie$80
- Davol Inc.$61
- Medtronic$35
- plus $11 from 1 others
What the payments were for
- Travel & lodging$95362%
- Food & beverage$44729%
- Gifts$1339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 5 | $1,001 |
| Braintree Laboratories, Inc. | 4 | $174 |
| Johnson & Johnson | 5 | $170 |
| AbbVie | 1 | $80 |
| Davol Inc. | 2 | $61 |
| Medtronic | 2 | $35 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,533 in reported general payments places this provider in the 50th percentile of 381 surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 42 | $821 |
| Famotidine | 53 | $726 |
| Omeprazole | 50 | $593 |
| Pantoprazole Sodium | 36 | $376 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $249 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $170 |
| Esomeprazole Magnesium | 12 | $126 |
| Metoclopramide Hcl | 18 | $17 |
Paid to pharmacies, not to this prescriber.
Other surgery in Pineville
- John TaborBaton Rouge$567K
- Carlos GalvaniNew Orleans$352K
- Mark HausmannBaton Rouge$250K
- Joseph BuellNew Orleans$186K
- Daryl MarxBaton Rouge$157K
- Matias NautsLake Charles$112K
- Tracee ShortBaton Rouge$108K
- Kamel BraktaShreveport$95K
- Kerry ThibodeauxOpelousas$84K
- Michael CookNew Orleans$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.